Early use of isotretinoin suppresses acne recurrence in children

 In a study of the use of isotretinoin in pediatric acne and its impact on outcomes, 90 children aged 9-18 years with acne (67.8% girls, mean age 13.5 years) were treated with isotretinoin. Clinical evaluations were performed monthly and one of the eligibility criteria included physician visits. Patients were divided according to age into Group A (9-11 years, 30), Group B (12-13 years, 30), and Control Group C (14-18 years, 30).


As a result, groups A and B completed treatment 2 months after confirmation of clinical improvement (mean 3 months). Group C, the control, received treatment at a mean cumulative dose of 135 mg/kg/day. Thirteen in groups A and B received a second acne treatment, using 3.33% oral isotretinoin, 18.33% topical. In group C, all 30 people received a second acne treatment. Acne scars and post-acne hyperpigmentation were reported in 73.33% of Group C. The researchers concluded that early, rational, short-term use of isotretinoin can reduce future acne breakouts and secondary acne symptoms.

Comments

Popular posts from this blog

L'Oréal forms research and technology alliance with Israeli climate tech company

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

L'Oreal Research & Innovation, Morishita Jintan Co., Ltd. and L'Oreal's first successful development of cutting-edge "active delivery capsules" made of useful ingredients for plant-derived cosmetics